• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Bicycle Health Secures $50M for Virtual Opioid Use Disorder Treatment

by Fred Pennic 06/07/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Bicycle Health Secures $50M for Virtual Opioid Use Disorder Treatment

What You Should Know:

Bicycle Health, a Boston, MA-based provider of virtual opioid addiction treatment raises $50M in Series B funding led by InterAlpen Partners, bringing the company’s total funds raised to $83 million. Other participants in the round include existing investors Questa Capital, Frist Cressey Ventures, and City Light Capital.

Evidence-based, online suboxone treatment for opioid addiction

Founded in 2017, Bicycle Health provides confidential, convenient and clinically-validated Medications for Addiction Treatment (MAT) and Integrated Behavioral Health support via telemedicine, for the treatment of opioid use disorder. Available in over 20 states and growing, Bicycle Health creates customized treatment plans for each patient, delivered by a team of medical providers, behavioral health clinicians and clinical support specialists.

Treatment is delivered virtually and includes synchronous and asynchronous access to the patient’s care team, same-day prescription refills for medication management, access to peer support groups and psychotherapy, and regular in-home diagnostics testing to monitor a patient’s progress. Bicycle Health also provides referrals to primary care and community support services to address Social Determinants of Health.

Recent Traction/Milestones

As a virtual OUD provider, the company currently offers the largest national coverage  (over 15k patients) and is available across the most number of states, expanding into its 25th, Delaware, in May 2022. Bicycle Health is also the first and only virtual provider in the OUD space to publish a peer-reviewed study proving the efficacy of its telehealth model.

Bicycle Health’s latest funding round will be used to continue growing the company’s team of clinical and technology innovators, advance its virtual care platform, expand access to its care through strategic partnerships, and develop even more research into the efficacy and outcomes of its virtual, Medications for Addiction Treatment (MAT) model for patients at all steps of their OUD recovery journey.

Today’s news comes on the heels of a year of substantial momentum for Bicycle Health – including its expansion into 7 new states and the 134% growth of the Bicycle Health team since 2021. With 10 million people across America who stand to benefit from Bicycle Health, the company has only continued to grow and is currently projected to save the healthcare system nearly $25.9 billion by 2026.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Behavioral Health, Behavioral Healthcare, Bicycle Health, medication, model, Opioid Epidemic, Partners, Primary Care, Social Determinants of Health, telemedicine, Virtual Care, Virtual Care Platform

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |